Midway Pharmaceuticals Inc.
This article was originally published in Start Up
Executive Summary
Midway Pharmaceuticals Inc. has a non-antibiotic approach to the raging problem of hospital-acquired infections. Its Polymer BioShield is a high molecular weight polyethylene glycol that when ingested has a multifactorial effect in the gut. It acts as an artificial barrier in situations where a patient's own mucousal barrier has been compromised. Perhaps more importantly, it appears to affect bacterial signaling, preventing pathogens from ganging up and launching an attack.